Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Early eMDR Adopters Share Tips On High-, Low-Volume Systems

This article was originally published in The Gray Sheet

Executive Summary

Whether they file 500 Medical Device Reports a year or five, device companies new to electronic MDR reporting should get their feet wet with FDA's eSubmitter and Web Trader tools, industry reps say

You may also be interested in...

eMDR 101: Experts Show Companies The e-Submissions Ropes

Though the date to comply with FDA's new electronic adverse event reporting requirements is still some time away, groups are already gearing up to guide firms through the complex new process

Device Firms Want Two Years To Comply With Electronic MDR Rule

Covidien, AdvaMed and the Medical Imaging and Technology Alliance are asking FDA to give device manufacturers two years to comply with an upcoming rule requiring adverse event reports to be submitted to the agency electronically

ACC 2020: Medtronic’s Resolute Onyx DES Meets Goals In US/Japan Low-Risk Trial

The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts